Stockreport

BriaCell gains after update on late-stage trial for lead asset [Seeking Alpha]

BriaCell Therapeutics Corp. - Common Shares  (BCTX) 
PDF biotech said that patient enrollment in its Phase 3 pivotal trial for lead candidate Bria-IMT in breast cancer is on track for completion by mid-2025. The company adde [Read more]